China's Premier Medical Device Investment Summit to Be Held in Shanghai, Co-Hosted by Life Capital and Johnson & Johnson Innovation JLABS

VCBeat (WeChat ID: vcbeat) has learned that the “2018 Inaugural Medical Device Investment and Financing Summit,” co-hosted by Life Capital and Johnson & Johnson JLABS, will be held in Shanghai on September 20, 2018.

Themed “China’s New Generation of Medical Devices,” this conference will focus on innovation and investment trends in technology, products, services, and business models within the medical device industry. It aims to establish a platform for financing and investment exchange and collaboration between enterprises and investment institutions, fostering win-win outcomes for projects and capital, and accelerating the rapid development of China’s medical device industry.

At that time, investors from 50 top venture capital firms, including Fosun Pharma, Legend Capital, Ping An Ventures, and Qiming Venture Partners, along with 50 high-quality medical device startup projects from entities such as the Medical Equipment Branch of the China General Chamber of Commerce’s Pharmaceutical Industry Chamber and the Shanghai Zhangjiang Hi-Tech Park, will convene in Shanghai to share their practical experience in the medical device sector and explore opportunities for collaboration.

For a long time, Chinese medical device companies have favored the path of import substitution, targeting the domestic market with technology slightly inferior to that of multinational corporations but offering higher cost-performance ratios. However, in recent years, driven by advancements in China’s scientific and technological capabilities and supportive national policies, we have seen an increasing number of medical device enterprises—particularly in specific niche segments—possessing proprietary intellectual property rights and technologies on par with those of multinational corporations. Chinese medical devices are gradually expanding into the global market.

Consequently, the capital markets have demonstrated strong interest in investing in medical devices. Outstanding companies that combine cutting-edge technological prowess with a global perspective have become highly sought-after targets for investors.

According to statistics from VCBeat, the medical device industry saw a total of 84 financing events (including 8 IPOs) in 2017, with a cumulative amount of nearly $1.6 billion (approximately RMB 10 billion). Capital primarily flowed into niche sectors such as in vitro diagnostics, radiation medicine, medical imaging, ultrasound equipment, medical robots, endoscopic minimally invasive devices, rehabilitation medicine, and home medical equipment. This demonstrates that every segment of China’s medical device industry holds significant promise, given that China is the world’s second-largest medical device market after the United States.

Against this backdrop, Life Capital, in partnership with JLABS by Johnson & Johnson, is hosting this investment and financing summit. The event aims to facilitate seamless funding and efficient implementation for medical device projects through face-to-face exchanges between top-tier investment institutions and innovative enterprises.

Life Capital, the organizer of this conference, is a leading financial advisory firm in China specializing in the life sciences and healthcare sectors. The company is dedicated to advancing progress in life sciences and healthcare through the power of capital. Its team members hail from renowned investment banks, academic institutions, and healthcare enterprises, bringing decades of accumulated expertise in the medical and investment financing fields. Over the past two years, the team has completed more than ten financing and mergers and acquisitions transactions in the healthcare industry, with a cumulative value reaching billions of RMB. These deals span various healthcare subsectors, including new drug development, medical devices, diagnostics, healthcare services, and smart healthcare.

In order to"Connecting the most promising startups with the most professional investors.", Life Capital pioneered the “Investment and Financing Summit,” featuring 50 entrepreneurs and 50 investors engaging in one-on-one direct communication. The summit adheres to three core principles: 1) Focus—each summit concentrates exclusively on a single niche sector within healthcare; 2) Professionalism—only the most outstanding projects and investors are invited to participate; 3) Exclusivity—no presentation sessions are held, with the entire event dedicated to one-on-one interactions. The new drug investment and financing summit hosted by Life Capital this June received widespread acclaim from both founders of innovative drug companies and investors.

Regarding the Medical Device Investment and Financing Summit, Li Hao, CEO of Vitality Capital, stated: “This conference will bring together 50 top-tier medical investment institutions in China, representing a massive pool of industrial funds exceeding RMB 100 billion. All attendees will undergo rigorous screening; investors must have experience in medical device investments, and founders must pass an initial review by an expert panel. Through a two-way selection and matching process, all selected founders will receive complimentary one-on-one coaching prior to the event to help medical device companies refine their key highlights and financing narratives.”

“Through this conference, we aim to facilitate precise connections between participating medical device companies and frontline investors in the market. In particular, attendees will have the opportunity to engage with global healthcare leaders such as Johnson & Johnson and top-tier medical funds, learn from their advanced practices, identify areas for improvement, secure appropriate capital, and achieve stronger future growth. Meanwhile, investors can efficiently evaluate 50 pre-screened, high-quality medical device companies in a single event, significantly enhancing their deal-sourcing efficiency.”

Johnson & Johnson, another organizer and the world’s largest healthcare conglomerate, has long maintained a strong positive outlook on China’s medical device market and innovation in the medical device sector. Last December, J&J Innovation partnered with the Shanghai Municipal Government, the Pudong New Area Government, and Zhangjiang Group to co-establish “Shanghai JLABS.”

Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems that empowers innovators to deliver life-saving health solutions and improve quality of life for patients worldwide at an accelerated pace. By providing emerging companies with an optimal environment to foster growth and optimize their research and development, offering critical industry connections, supporting entrepreneurial initiatives, and delivering capital-efficient, flexible platforms, JLABS enables them to translate current scientific discoveries into breakthrough medical solutions for the future.

JLABS is a no-strings-attached business model, meaning entrepreneurs are free to develop their science and technology while retaining full ownership of their intellectual property. JLABS is open to entrepreneurs across a broad spectrum of the healthcare sector, including the pharmaceutical, medical device, consumer health, and digital health industries.

JLABS, in collaboration with Life Capital, is hosting a Medical Device Investment and Financing Summit. Through this event, we aim to connect with more outstanding domestic medical device startups, foster deeper exchanges and cooperation, and support the growth of high-potential enterprises.

Click the image to register now